The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has filed a Form 8.3 with the Irish Takeover Panel regarding Mural Oncology plc. As of 16 July 2025, Vanguard holds a 4.47% interest in $0.01 ordinary shares, totaling 772,595 shares, with no short positions. This disclosure complies with Rule 8.3 of the Irish Takeover Panel Act, 1997.

No additional interests or short positions were reported in other classes of Mural Oncology securities. The form specifies no dealings in cash-settled or stock-settled derivatives. Only a minor transaction of 16 shares sold at $2.47 each was noted.

There are no indemnity or dealing arrangements, and no relevant agreements concerning options or derivatives. No supplemental documentation is attached. These disclosures ensure transparency in compliance with takeover rules.